SCHEMBL1452909

SCHEMBL1452909

C[CH]CC(C)Sc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
SLC6A4 P31645 1/20 0.35
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
PKM P14618 1/20 0.34
HTR2A P28223 3/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
MGLL Q99685 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MTNR1A P48039 3/20 0.33
MTNR1B P49286 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4699950 0.82 MAOA (0.38) MAOAMAOBSLC6A4ALDH1A1L3MBTL1
SCHEMBL1453173 0.81 MAOA (0.36) MAOAMAOBSLC6A4ALDH1A1L3MBTL1
SCHEMBL1454233 0.80 MAOA (0.37) MAOAMAOBSLC6A4ALDH1A1L3MBTL1
SCHEMBL1454262 0.77 MAOA (0.35) MAOAMAOBSLC6A4ALDH1A1L3MBTL1
SCHEMBL1453943 0.76 ALDH1A1 (0.36) MAOAMAOBALDH1A1L3MBTL1KDM4E
SCHEMBL1453904 0.76 L3MBTL1 (0.45) MAOAMAOBSLC6A4ALDH1A1L3MBTL1
SCHEMBL585722 0.74 MAOA (0.42) MAOAMAOBSLC6A4ALDH1A1L3MBTL1
SCHEMBL9052050 0.74 TRPA1 (0.42) MAOAMAOBSLC6A4ALDH1A1L3MBTL1
Fluoride SCHEMBL1335974 0.74 MAOA (0.47) MAOAMAOBSLC6A4ALDH1A1L3MBTL1
SCHEMBL1454786 0.74 MAOA (0.42) MAOAMAOBSLC6A4ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910617-B2 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound SANKYO COMPANY, LIMITED (JP) 2011-03-22 US disclosed
US-20070191468-A1 Amino alcohol compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2007-08-16 US disclosed
EP-1733724-A1 AMINO ALCOHOL COMPOUND Sankyo Company, Limited (JP) 2006-12-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191468-A1 Amino alcohol compound ADH1A, ADH1C, BCAT1 MAOA 2055/4885MAOB 1138/4885SLC6A4 1912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.